Figure 3.
Trend of changes in electroretinogram amplitude (Mvolt) from baseline to 6 months in the treatment (saffron) and control (placebo) groups of patients with dry and wet age-related macular degeneration (AMD).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.